172 related articles for article (PubMed ID: 36114172)
21. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.
Wang LH; Friedman SD; Shaw D; Snider L; Wong CJ; Budech CB; Poliachik SL; Gove NE; Lewis LM; Campbell AE; Lemmers RJFL; Maarel SM; Tapscott SJ; Tawil RN
Hum Mol Genet; 2019 Feb; 28(3):476-486. PubMed ID: 30312408
[TBL] [Abstract][Full Text] [Related]
22. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
[TBL] [Abstract][Full Text] [Related]
23. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
[TBL] [Abstract][Full Text] [Related]
24. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
[TBL] [Abstract][Full Text] [Related]
25. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
[TBL] [Abstract][Full Text] [Related]
26. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
[TBL] [Abstract][Full Text] [Related]
27. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
[TBL] [Abstract][Full Text] [Related]
28. Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy.
Mueller AL; O'Neill A; Jones TI; Llach A; Rojas LA; Sakellariou P; Stadler G; Wright WE; Eyerman D; Jones PL; Bloch RJ
Exp Neurol; 2019 Oct; 320():113011. PubMed ID: 31306642
[TBL] [Abstract][Full Text] [Related]
29. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.
Dmitriev P; Stankevicins L; Ansseau E; Petrov A; Barat A; Dessen P; Robert T; Turki A; Lazar V; Labourer E; Belayew A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
J Biol Chem; 2013 Dec; 288(49):34989-5002. PubMed ID: 24145033
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning.
Monforte M; Bortolani S; Torchia E; Cristiano L; Laschena F; Tartaglione T; Ricci E; Tasca G
J Neurol; 2022 Apr; 269(4):2055-2063. PubMed ID: 34486074
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
[TBL] [Abstract][Full Text] [Related]
32. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
[TBL] [Abstract][Full Text] [Related]
33. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
Cheli S; François S; Bodega B; Ferrari F; Tenedini E; Roncaglia E; Ferrari S; Ginelli E; Meneveri R
PLoS One; 2011; 6(6):e20966. PubMed ID: 21695143
[TBL] [Abstract][Full Text] [Related]
35. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
Elife; 2016 Nov; 5():. PubMed ID: 27841748
[TBL] [Abstract][Full Text] [Related]
36. DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.
Lim KRQ; Nguyen Q; Yokota T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979100
[TBL] [Abstract][Full Text] [Related]
37. ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy.
Arbogast S; Kotzur H; Frank C; Compagnone N; Sutra T; Pillard F; Pietri S; Hmada N; Moussa DMA; Bride J; Françonnet S; Mercier J; Cristol JP; Dabauvalle MC; Laoudj-Chenivesse D
Redox Biol; 2022 Oct; 56():102450. PubMed ID: 36030628
[TBL] [Abstract][Full Text] [Related]
38. Upper girdle imaging in facioscapulohumeral muscular dystrophy.
Tasca G; Monforte M; Iannaccone E; Laschena F; Ottaviani P; Leoncini E; Boccia S; Galluzzi G; Pelliccioni M; Masciullo M; Frusciante R; Mercuri E; Ricci E
PLoS One; 2014; 9(6):e100292. PubMed ID: 24932477
[TBL] [Abstract][Full Text] [Related]
39. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.
Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A
NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146
[TBL] [Abstract][Full Text] [Related]
40. Gene expression during normal and FSHD myogenesis.
Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]